◂ Announcements

Dec 20, 2021CONTRACTCanada

Lumos Diagnostics receives initial orders for CoviDx in Canada

Lumos Diagnostics received initial orders worth approximately US$250,000 for its CoviDx SARS-CoV-2 rapid antigen test in Canada, expected to ship in December 2021.

Value

$250K

Status

Completed

ProductsCoviDx SARS-CoV-2 rapid antigen test

CompaniesLumos Diagnostics

Sectors#Medical Devices

“We are pleased with these initial commercial orders for CoviDx so soon after receiving our Interim Order authorisation from Health Canada.”listcorp.com

1 source
listcorp.comLumos Receives Initial Orders for CoviDx In Canada - Lumos Diagnostics Holdings Limited (ASX:LDX) - Listcorp.Dec 19, 2021

Summarized from public sources; check the original articles before acting on it.

More from Lumos Diagnostics

profile ▸

Jul 16, 2025CONTRACTUnited States$2.00M
Lumos Diagnostics signs exclusive U.S. distribution deal with PHASE Scientific for FebriDx
Lumos Diagnostics PHASE Scientific customer lumosdiagnostics.com
Feb 3, 2022NEW FACILITYMelbourne, Victoria, Australia70 jobsops Apr 2022
Planet Innovation and Lumos Diagnostics to open rapid antigen test facility in Melbourne
Planet Innovation Lumos Diagnostics partner aumanufacturing.com.au

Loading…

Lumos Diagnostics receives initial orders for CoviDx in Canada · Endata